A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 17, 2014

Primary Completion Date

May 23, 2014

Study Completion Date

May 23, 2014

Conditions

Hypertension

Interventions

DRUG

GSK587323

Single dose of FDC tablet formulation to be taken orally.

DRUG

FDC of candesartan cilexetil 16 mg and HCTZ 12.5mg

Single dose of FDC tablet formulation to be taken orally

Trial Locations (1)

GSK Investigational Site, Hyderabad